Ideal Power Announces Closing of $14 Million Financing of Common Stock

Rhea-AI Summary

Ideal Power (Nasdaq:IPWR) closed an underwritten public offering of 4,458,736 shares (or pre-funded warrants) and a concurrent private placement of pre-funded warrants for up to 631,332 shares, generating approximately $14.0 million gross proceeds on February 25, 2026.

The financing included participation from the company's largest institutional shareholders and insiders, including the CEO. Net proceeds are intended to advance commercialization of B-TRAN, support customer design-ins, custom development, initial production ramp with partners, and general corporate purposes.

Positive

• $14.0M gross proceeds closed
• Financing led by largest institutional shareholders
• Proceeds earmarked to advance B-TRAN commercialization

Negative

• Issuance of 4,458,736 shares and pre-funded warrants may dilute shareholders
• Underwriting discounts and offering expenses reduce net proceeds
• Private placement shares are unregistered pending resale registration

Argus Feb 26 session

+14.24% close to close Open Argus

Details

News Market Reaction – IPWR

On Feb 26, the first trading day after this news, IPWR closed 14.24% above the previous close.

Data tracked by StockTitan Argus for the Feb 26 session.

Key Figures

Public offering shares: 4,458,736 shares Private placement warrants: 631,332 shares Gross proceeds: $14.0 million +1 more

Public offering shares

4,458,736 shares

Underwritten public offering of common stock (or pre-funded warrants)

Private placement warrants

631,332 shares

Pre-funded warrants in concurrent private placement

Gross proceeds

$14.0 million

Total gross proceeds from public offering and private placement

Registration number

No. 333-292492

Form S-3 registration statement referenced for the public offering

Historical Context

5 past events · Latest: Feb 24

5 events

1. Feb 24

   Business update call

   24h Move

   -8.6%

   Announcement of upcoming webcast and Q&A session with management.

2. Feb 23

   Financing priced

   24h Move

   -8.7%

   Pricing of $14M public offering and concurrent private placement.

3. Feb 23

   Offering proposed

   24h Move

   -8.7%

   Proposed underwritten public offering under effective Form S-3 shelf.

4. Dec 09

   Product upgrade

   24h Move

   +0.5%

   Increased B-TRAN discrete device rating from 50A to 75A after testing.

5. Nov 13

   Q3 2025 results

   24h Move

   -26.8%

   Q3 loss, low revenue, cash burn and going‑concern disclosure.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

underwritten public offering, pre-funded warrants, private placement, prospectus supplement, +1 more

5 terms

underwritten public offering financial

"announced it has closed its previously announced underwritten public offering of 4,458,736"

An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.

pre-funded warrants financial

"public offering of 4,458,736 shares of common stock (or pre-funded warrants in lieu thereof)"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

private placement financial

"and the concurrent private placement of pre-funded warrants to purchase up to 631,332"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

prospectus supplement regulatory

"only by means of a preliminary prospectus supplement and a final prospectus supplement"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

resale registration statement regulatory

"has agreed to file a resale registration statement with the SEC for purposes of"

A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The financing was led by the company's largest existing institutional shareholders, with participation from Ideal Power insiders, including its CEO

AUSTIN, Texas, Feb. 25, 2026 /PRNewswire/ -- Ideal Power Inc. (Nasdaq:IPWR) ("Ideal Power," the "Company," "we," or "our"), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, today announced it has closed its previously announced underwritten public offering of 4,458,736 shares of common stock (or pre-funded warrants in lieu thereof) and the concurrent private placement of pre-funded warrants to purchase up to 631,332 shares of common stock. Total gross proceeds from the financings are approximately $14.0 million, before deducting underwriting discounts, commissions, and other offering expenses payable by the Company. The public offering included participation from existing institutional shareholders and Company insiders, including our Chief Executive Officer.

The Company intends to use the net proceeds from these financings to advance commercialization of B-TRAN®, including customer design-ins, custom development programs, and initial production ramp with strategic partners, and for general corporate and working capital purposes.

Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the financing. WestPark Capital, Inc. served as a financial advisor to the Company.

The public offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-292492) (including a base prospectus) previously filed with the U.S. Securities and Exchange Commission (the "SEC") on December 30, 2025, and declared effective on January 9, 2026. The public offering was made only by means of a preliminary prospectus supplement and a final prospectus supplement and the accompanying base prospectus that form a part of the registration statement. These documents, including the preliminary prospectus supplement relating to the offering, are available for free on the SEC's website at www.sec.gov. Copies of the final prospectus supplement and the accompanying base prospectus relating to the offering may be accessed for free on the SEC's website at www.sec.gov or obtained by contacting Titan Partners Group LLC, a division of American Capital Partners, LLC, 4 World Trade Center, 49th Floor, New York, NY 10007, by phone at (929) 833-1246 or by email at prospectus@titanpartnersgrp.com.

The securities issued in the Private Placement described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. The Company has agreed to file a resale registration statement with the SEC for purposes of registering the resale of the shares of common stock underlying the pre-funded warrants issued in connection with the Private Placement.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Ideal Power Inc.
Ideal Power (NASDAQ: IPWR) is the developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch. B-TRAN® offers compelling advantages over conventional technologies and addresses the demanding standards of today's solid-state circuit protection and intelligent power delivery systems. It features very low conduction losses that deliver improved power efficiency, thereby reducing energy consumption and providing cost savings. The unique bidirectional capability of B-TRAN® simplifies the design, control and diagnostics of solid-state power solutions while enabling smaller, lower cost systems. B-TRAN® delivers compelling advantages for a broad spectrum of applications including solid-state circuit breakers, static transfer switches, battery disconnect units and EV contactors that are widely used in data centers, industrial power systems, energy grid and storage systems, and electric vehicles and charging infrastructure.

Safe Harbor Statement
All statements in this release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While Ideal Power's management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Such forward-looking statements include, but are not limited to, statements regarding the financings and the intended use of proceeds. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the success of our B-TRAN^® technology, including whether the patents for our technology provide adequate protection and whether we can be successful in maintaining, enforcing and defending our patents, our inability to predict with precision or certainty the pace and timing of development and commercialization of our B-TRAN^® technology, the rate and degree of market acceptance for our B-TRAN^®, the impact of global health pandemics on our business, supply chain disruptions, and the expected performance of future products incorporating our B-TRAN^®, and uncertainties set forth in our quarterly, annual and other reports filed with the SEC. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements, except as required by applicable law.

Ideal Power Investor Relations Contact: 

Jeff Christensen
Darrow Associates Investor Relations
jchristensen@darrowir.com
703-297-6917

View original content to download multimedia:https://www.prnewswire.com/news-releases/ideal-power-announces-closing-of-14-million-financing-of-common-stock-302697576.html

SOURCE IDEAL POWER INC.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Ideal Power (IPWR) raise in the February 25, 2026 financing?

Ideal Power raised approximately $14.0 million in gross proceeds from the public offering and private placement. According to the company, that total is before underwriting discounts, commissions, and other offering expenses payable by the company.

What securities did Ideal Power (IPWR) issue in the February 25, 2026 offering?

Ideal Power issued 4,458,736 shares (or pre-funded warrants) and pre-funded warrants for up to 631,332 shares. According to the company, the private placement securities are unregistered and subject to resale registration.

Who participated in Ideal Power's (IPWR) February 25, 2026 financing?

The financing included participation from the company's largest existing institutional shareholders and insiders, including the chief executive officer. According to the company, Titan Partners acted as sole bookrunner and WestPark Capital served as financial advisor.

How will Ideal Power (IPWR) use the proceeds from the $14.0M financing?

The company intends to use net proceeds to advance B-TRAN commercialization, including customer design-ins, custom development programs, and initial production ramp with partners. According to the company, remaining funds are for general corporate and working capital purposes.

Will the February 25, 2026 offering affect Ideal Power (IPWR) shareholders?

The offering adds newly issued shares and pre-funded warrants, which may dilute existing shareholders' ownership percentages. According to the company, gross proceeds are approximately $14.0 million before underwriting discounts and offering expenses.